Robert Friedman, DMD

Robert Friedman, DMD in New York, NY, operates as Bard Cancer Diagnostics, focusing on non-invasive cancer imaging. The center is committed to leveraging cutting-edge diagnostic technologies to formulate tailored treatment plans for various cancer types. Additionally, it specializes in preventive solutions for individuals aiming to lead health-conscious lifestyles or those at heightened risk due to genetic or environmental factors.

The facility emphasizes the importance of accurate diagnoses to establish personalized treatment strategies. Utilizing state-of-the-art 3D imaging, patients can visually comprehend their condition during examinations. Bard Cancer Diagnostics prides itself on offering unparalleled expertise, boasting a team of specialists trained in advanced imaging protocols from 11 different countries.

With a legacy of 50 years in pioneering CT, MRI, and Ultrasound technologies, the center ensures access to FDA-approved scans not widely available in the USA. Patients can benefit from breakthrough treatments for various cancers, including prostate, breast, thyroid, melanoma, and skin cancer. Bard Cancer Diagnostics optimizes minimally invasive procedures to minimize damage to surrounding tissues through innovative 3D tumor margin mapping techniques.

Generated from the website content